Collie Jake T B, Massie R John, Jones Oliver A H, LeGrys Vicky A, Greaves Ronda F
School of Applied Sciences, RMIT University, Melbourne, Victoria, Australia; Dorevitch Pathology, Heidelberg, Victoria, Australia; Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Pediatr Pulmonol. 2014 Feb;49(2):106-17. doi: 10.1002/ppul.22945. Epub 2013 Nov 19.
The sweat test remains important as a diagnostic test for cystic fibrosis (CF) and has contributed greatly to our understanding of CF as a disease of epithelial electrolyte transport. The standardization of the sweat test, by Gibson and Cooke [Gibson and Cooke (1959) Pediatrics 1959;23:5], followed observations of excessive dehydration amongst patients with CF and confirmed the utility as a diagnostic test. Quantitative pilocarpine iontophoresis remains the gold standard for sweat induction, but there are a number of collection and analytical methods. The pathophysiology of electrolyte transport in sweat was described by Quinton [Quinton (1983) Nature 1983;301:421-422], and this complemented the developments in genetics that discovered the cystic fibrosis transmembrane conductance regulator (CFTR), an epithelial-based electrolyte transport protein. Knowledge of CF has since increased rapidly and further developments in sweat testing include: new collection methods, further standardization of the technique with international recommendations and age related reference intervals. More recently, sweat chloride values have been used as proof of effect for the new drugs that activate CFTR. However, there remain issues with adherence to sweat test guidelines in many countries and there are gaps in our knowledge, including reference intervals for some age groups and stability of sweat samples in transport. Furthermore, modern methods of elemental quantification need to be explored as alternatives to the original analytical methods for sweat electrolyte measurement. The purpose of this review is therefore to describe the development of the sweat test and consider future directions.
汗液测试作为囊性纤维化(CF)的诊断测试仍然很重要,并且极大地促进了我们对CF作为一种上皮电解质转运疾病的理解。Gibson和Cooke [Gibson和Cooke(1959年)《儿科学》1959年;23:5] 对汗液测试进行了标准化,此前观察到CF患者存在过度脱水情况,并证实了该测试作为诊断测试的效用。定量毛果芸香碱离子电渗疗法仍然是诱导出汗的金标准,但有多种采集和分析方法。Quinton [Quinton(1983年)《自然》1983年;301:421 - 422] 描述了汗液中电解质转运的病理生理学,这补充了遗传学方面的进展,遗传学发现了囊性纤维化跨膜传导调节因子(CFTR),一种基于上皮的电解质转运蛋白。此后,对CF的认识迅速增加,汗液测试的进一步发展包括:新的采集方法、根据国际建议对该技术进行进一步标准化以及与年龄相关的参考区间。最近,汗液氯化物值已被用作激活CFTR的新药疗效的证据。然而,许多国家在遵守汗液测试指南方面仍然存在问题,并且我们的知识存在空白,包括一些年龄组的参考区间以及汗液样本在运输过程中的稳定性。此外,需要探索现代元素定量方法作为汗液电解质测量原始分析方法的替代方法。因此,本综述的目的是描述汗液测试的发展并考虑未来方向。